Clinical trials
Urinary Bladder Neoplasms trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 3 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Active, not recruiting | 10 |
| Recruiting | 8 |
| Terminated | 7 |
| Unknown status | 6 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 8 |
| UroGen Pharma Ltd. | 6 |
| Bristol-Myers Squibb | 4 |
| European Organisation for Research and Treatment of Cancer - EORTC | 4 |
| AstraZeneca | 3 |
| Eli Lilly and Company | 2 |
| Meir Medical Center | 2 |
| Pfizer | 2 |
| Rabin Medical Center | 2 |
| Seagen, a wholly owned subsidiary of Pfizer | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 56 |
| Non-Muscle Invasive Bladder Neoplasms | 11 |
| Carcinoma, Transitional Cell | 10 |
| Urologic Neoplasms | 6 |
| Neoplasms | 5 |
| Prostatic Neoplasms | 5 |
| Ovarian Neoplasms | 4 |
| Stomach Neoplasms | 4 |
| Triple Negative Breast Neoplasms | 4 |
| Urethral Neoplasms | 4 |
Trials
Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.